The DOI matches its Crossref record; 85 of the 89 references it cites were found in a registry or an index.
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite
Open accessPublished version of a preprint
Abstract
Numerous antibodies that neutralize SARS-CoV-2 have been identified, and these generally target either the receptor-binding domain (RBD) or the N-terminal domain (NTD) of the viral spike. While RBD-directed antibodies have been extensively studied, far less is known about NTD-directed antibodies. Here, we report cryo-EM and crystal structures for seven potent NTD-directed neutralizing antibodies in complex with spike or isolated NTD. These structures defined several antibody classes, with at least one observed in multiple convalescent donors. The structures revealed that all seven antibodies target a common surface, bordered by glycans N17, N74, N122, and N149. This site-formed primarily by a mobile β-hairpin and several flexible loops-was highly electropositive, located at the periphery of the spike, and the largest glycan-free surface of NTD facing away from the viral membrane. Thus, in contrast to neutralizing RBD-directed antibodies that recognize multiple non-overlapping epitopes, potent NTD-directed neutralizing antibodies appear to target a single supersite.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neutralizing mAbs that bind regions of the viral spike have also been identified (24, 33, 38–42).”
From mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection (2021) · cites this paper as [40]
In the citing paper
“that would be predicted to disrupt the so-called “super site” on the NTD mediating neutralization (Cerutti et al., 2021; Figure S2)”
From Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum (2021) · cites this paper as Cerutti et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,882
MUSCLE: multiple sequence alignment with high accuracy and high throughput
Edgar, R. C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh340 · Cited by 44,662
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform
Katoh, K. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf436 · Cited by 17,027
SWISS-MODEL: homology modelling of protein structures and complexes
Waterhouse, A. M., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T., Rempfer, C., Bordoli, L., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky427 · Cited by 13,248
Overview of the CCP 4 suite and current developments
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 10,007
Flagged first, then by citations
4 of the 89 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 524
Architects of infection: A structural overview of SARS-related coronavirus spike glycoproteins
Hills, F. R., Geoghegan, J. L., & Bostina, M. (2025) · Virology · doi:10.1016/j.virol.2024.110383 · Cited by 10
Ehteshaminia, Y., Jalali, S. F., Jadidi‐Niaragh, F., Enderami, S. E., Pagheh, A. S., Akbari, E., Abediankenari, S., & Hassannia, H. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121525 · Cited by 9
Khadela, A. D., Soni, S., Megha, K., Bhagat, S. U., & Chavda, V. P. (2023) · Biologics · doi:10.3390/biologics3020008 · Cited by 9
Multifaceted membrane binding head of the SARS-CoV-2 spike protein
Tran, A., Kervin, T. A., & Overduin, M. (2022) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2022.05.001 · Cited by 8
Liu, W., & hualan, L. (2023) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000455 · Cited by 9
Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage
Zhang, L., Dopfer‐Jablonka, A., Nehlmeier, I., Kempf, A. M., Graichen, L., Hampel, N. C., Cossmann, A., Stankov, M. V., Ramos, G. M., Schulz, S. R., et al. (2024) · Vaccines · doi:10.3390/vaccines12050487 · Cited by 8
SARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus ImmunogenicityPreprint
Joyce, M. G., Chen, W., Sankhala, R. S., Hajduczki, A., Thomas, P. V., Choe, M., Martinez, E. J., Chang, W. C., Peterson, C. E., Morrison, E. B., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3854502 · Cited by 9
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domainsPreprint
Stewart-Jones, G. B. E., Elbashir, S. M., Wu, K., Lee, D. W., Renzi, I., Ying, B., Koch, M., Sein, C. E., Choi, A., Whitener, B. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.07.511319 · Cited by 9
O’Reilly, S. R., Byrne, J., Feeney, E. R., Mallon, P. W. G., & Gautier, V. (2024) · Vaccines · doi:10.3390/vaccines12101089 · Cited by 8
Zhang, Z., Zhang, Y., Zhang, Y., Cheng, L., Zhang, L., Yan, Q., Liu, X., Chen, J., Dai, J., Guo, Y., et al. (2024) · MedComm · doi:10.1002/mco2.70008 · Cited by 8
Self-citationA Structural Voyage Toward the Landscape of Humoral and Cellular Immune Escapes of SARS ‐ CoV ‐2
Liu, J., Wu, Y., & Gao, G. F. (2025) · Immunological Reviews · doi:10.1111/imr.70000 · Cited by 8
Oliveira, M. D. M., Schemberger, M. O., Suzukawa, A. A., Riediger, I. N., Debur, M. D. C., Becker, G., Resende, P. C., Gräf, T., Balsanelli, E., Baura, V. A., et al. (2021) · Virology Journal · doi:10.1186/s12985-021-01690-1 · Cited by 8
Bhiman, J. N., & Moore, P. L. (2022) · Immunological Reviews · doi:10.1111/imr.13086 · Cited by 7
Rienzo, L. D., Miotto, M., Desantis, F., Grassmann, G., Ruocco, G., & Milanetti, E. (2023) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26497 · Cited by 8
Poumbourios, P., Langer, C., Boo, I., Zakir, T., Akerman, A., Milogiannakis, V., Aggarwal, A., Johnstone, B. A., Ha, J., Coulibaly, F., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1010981 · Cited by 8
Olivier, T., Blomet, J., & Desmecht, D. J.-M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1197588 · Cited by 9
Rogozin, I. B., Saura, A., Poliakov, E., Bykova, A., Roche-Lima, A., Pavlov, Y. I., & Yurchenko, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073696 · Cited by 8
Identification of SARS-CoV-2 S RBD escape mutants using yeast screening and deep mutational scanning
Haas, C. M., Francino-Urdaniz, I. M., Steiner, P. J., & Whitehead, T. A. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100869 · Cited by 7
Emadi‐Baygi, M., Ehsanifard, M., Afrashtehpour, N., Norouzi, M., & Joz-Abbasalian, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.778913 · Cited by 8
Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera
Herrlein, M., Hein, S., Zahn, T. R., Mhedhbi, I., Raupach, J., Husria, Y., Benz, N. I., Eisert, J., Bender, D., Haberger, V., et al. (2022) · Viruses · doi:10.3390/v14020410 · Cited by 8
Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques
Willcox, A. C., Sung, K., Garrett, M. E., Galloway, J., O’Connor, M. A., Erasmus, J. H., Logue, J. K., Hawman, D. W., Chu, H. Y., Hasenkrug, K. J., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010155 · Cited by 9
Mukherjee, S., & Ray, S. K. (2022) · Infectious Disorders - Drug Targets · doi:10.2174/1871526522666220401101818 · Cited by 9
Jacot, D., von Rotz, U., Pellaton, C., Blondet, F., Aebischer, O., Perreau, M., Rham, M. D., Pantaleo, G., Marchetti, O., & Greub, G. (2022) · Microbes and Infection · doi:10.1016/j.micinf.2022.105077 · Cited by 7
Potent antibodies against immune invasive SARS-CoV-2 Omicron subvariants
Wang, L., Wang, Y., & Zhou, H. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125997 · Cited by 8
Ali, M. A., & Caetano‐Anollés, G. (2024) · Biology · doi:10.3390/biology13030134 · Cited by 11
Wang, Q., Guo, Y., Schwanz, L. T., Mellis, I. A., Sun, Y., Qu, Y., Urtecho, G., Valdez, R., Stoneman, E. K., Gordon, A. L., et al. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2359004 · Cited by 8
Self-citationConnor, R. I., Sakharkar, M., Rappazzo, G., Kaku, C. I., Curtis, N. C., Shin, S., Wieland‐Alter, W., Wentworth, J., Mielcarz, D. W., Weiner, J. A., et al. (2024) · Pathogens and Immunity · doi:10.20411/pai.v9i2.679 · Cited by 8
A large-scale systematic survey of SARS-CoV-2 antibodies reveals recurring molecular featuresPreprint
Wang, Y., Yuan, M., Peng, J., Wilson, I. A., & Wu, N. C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.26.470157 · Cited by 8
Two Sides of the Same Coin: the N-terminal and the Receptor-Binding Domains of SARS-CoV-2 Spike
Ciccozzi, M., & Pascarella, S. (2023) · Future Virology · doi:10.2217/fvl-2022-0181 · Cited by 8
Stäb, S., Pearce, N. M., Tronrud, D. E., Ginn, H. M., Fadda, E., Santoni, G., & Thorn, A. (2024) · Crystallography Reviews · doi:10.1080/0889311x.2024.2363756 · Cited by 7
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike
Duyvesteyn, H. M. E., Dijokaite-Guraliuc, A., Liu, C., Supasa, P., Kronsteiner, B., Jeffery, K. J., Stafford, L., Klenerman, P., Dunachie, S. J., Mongkolsapaya, J., et al. (2024) · Structure · doi:10.1016/j.str.2024.07.020 · Cited by 7
Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum Protection
Qiao, R., Li, J., Gong, J., Shao, Y., Yu, J., Chen, Y., Lu, Y., Yang, L., Lin, L., Hu, Z., et al. (2025) · Vaccines · doi:10.3390/vaccines13060635 · Cited by 8
Self-citationLamb, K. D., Hughes, J., Lytras, S., Young, F., Koci, O., Herzig, J. C., Lovell, S. C., Grove, J., Yuan, K., & Robertson, D. L. (2026) · Nature Communications · doi:10.1038/s41467-026-69569-9 · Cited by 20
Lv, H., Tsang, O. T., So, R. T. Y., Wang, Y., Yuan, M., Liu, H., Yip, G. K., Teo, Q. W., Lin, Y., Liang, W., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202149234 · Cited by 6
SARS-CoV-2 S Glycoprotein Stabilization Strategies
Pedenko, B., Sulbarán, G., Guilligay, D., Effantin, G., & Weissenhorn, W. (2023) · Viruses · doi:10.3390/v15020558 · Cited by 8
Azarias-da-Silva, M., Nioche, P., Soudaramourty, C., Bull-Maurer, A., Tiouajni, M., Kong, D., Zghidi‐Abouzid, O., Picard, M., Mendes‐Frias, A., Cruz, A. S., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg2122 · Cited by 6
A Reflection on the Use of Molecular Simulation to Respond to SARS-CoV-2 Pandemic Threats
Casalino, L., Ramos‐Guzmán, C. A., Amaro, R. E., Simmerling, C. L., Lodola, A., Mulholland, A. J., Świderek, K., & Moliner, V. (2025) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.4c03654 · Cited by 7
Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes
Hein, S., Benz, N. I., Eisert, J., Herrlein, M., Oberle, D., Dreher, M., Stingl, J., Hildt, C., & Hildt, E. (2021) · Vaccines · doi:10.3390/vaccines9121419 · Cited by 7
Sun, C., Yuan, R., Xie, C., Sun, J., Fang, X., Hu, Y., Yu, X., Liu, Z., Zeng, M., & Kang, Y. (2022) · Journal of Virology · doi:10.1128/jvi.00383-22 · Cited by 7
Should I Help? Prosocial Behaviour during the COVID-19 Pandemic
Wider, W., Lim, M. X., Wong, L. S., Chan, C. K., & Maidin, S. S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192316084 · Cited by 14
Miotto, M., Rienzo, L. D., Grassmann, G., Desantis, F., Cidonio, G., Gosti, G., Leonetti, M., Ruocco, G., & Milanetti, E. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1205919 · Cited by 7
Garushyants, S. K., Rogozin, I. B., & Koonin, E. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.23.441209 · Cited by 8
Stebliankin, V., Baral, P., Balbin, C. A., Nunez-Castilla, J., Sobhan, M., Cickovski, T., Mondal, A. M., Siltberg-Liberles, J., Chapagain, P. P., Mathee, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.05.479274 · Cited by 7
Jiang, W., Jiang, Y., Sun, H., Deng, T., Yu, K., Fang, Q., Ge, H., Lan, M., Lin, Y., Fang, Z., et al. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2406300 · Cited by 6
Zhang, S., Han, J., & Liu, J. (2024) · GigaScience · doi:10.1093/gigascience/giae080 · Cited by 5
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques
Letscher, H., Guilligay, D., Effantin, G., Amen, A., Sulbarán, G., Burger, J. A., Bossevot, L., Junges, L., Léonec, M., Morin, J., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01113-0 · Cited by 6
Chen, X., Li, L., Du, R., Wang, Z., Li, Y., Sun, Y., Qin, R., Feng, H., Hu, L., Chen, X., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115964 · Cited by 6
Functional and structural basis of Omicron BA.3.2.1 spike
Wang, Y., Hu, Y., Chen, Z., Zou, J., Zhang, K., Ren, P., Shi, P., Liang, B., & Xie, X. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117812 · Cited by 6
Tang, H., Ke, Y., Liao, Y., Bian, Y., Yuan, Y., Wang, Z., Li, Y., Ma, H., Sun, T., Zhang, B., et al. (2022) · Virologica Sinica · doi:10.1016/j.virs.2022.11.005 · Cited by 6
Self-citationDu, W., Janssens, R., Mykytyn, A. Z., Li, W., Drabek, D., van Haperen, R., Chatziandreou, M., Rissmann, M., van der Lee, J., van Dortmondt, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1111385 · Cited by 6
Yang, M., Luo, H., Fan, Z.-Y., Feng, Y.-X., Wei, N., Zhu, B., Ye, J., Cao, S., & Si, Y. (2023) · Infectious Medicine · doi:10.1016/j.imj.2023.09.001 · Cited by 6
Galeota, E., Bevilacqua, V., Gobbini, A., Gruarin, P., Bombaci, M., Pesce, E., Favalli, A., Lombardi, A., Vincenti, F., Ongaro, J., et al. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110164 · Cited by 6
Zhang, L., Tan, J. T., Ng, H. Y., Liao, Y., Zhang, R., Chan, K., Hung, I. F., Lam, T. T., & Cheung, K. S. (2024) · Vaccines · doi:10.3390/vaccines12040365 · Cited by 7
Seow, J., Jefferson, G. C. E., Keegan, M. D., Yau, Y., Snell, L. B., & Doores, K. J. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012724 · Cited by 6
Heptad stereotypy, S/Q layering, and remote origin of the SARS-CoV-2 fusion core
Marchetti, C., Vaglietti, S., Rizzo, F., Nardo, G. D., Colnaghi, L., Ghirardi, M., & Fiumara, F. (2021) · Virus Evolution · doi:10.1093/ve/veab097 · Cited by 5
Fibke, C. D., Joffres, Y., Tyson, J. R., Colijn, C., Janjua, N. Z., Fjell, C. D., Prystajecky, N., Jassem, A. N., & Sbihi, H. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.915363 · Cited by 7
Cheng, Y., Zheng, D., Zhang, D., Guo, D., Wang, Y., Liu, W. Y., Liang, L., Hu, J., Shi, H., & Luo, T. (2023) · Journal of Molecular Modeling · doi:10.1007/s00894-023-05509-4 · Cited by 6
Madan, B., Reddem, E. R., Wang, P., Casner, R. G., Nair, M. S., Huang, Y., Fahad, A. S., de Souza, M. O., Banach, B. B., Acevedo, S. N. L., et al. (2021) · AIChE Journal · doi:10.1002/aic.17440 · Cited by 6
Self-citationShi, J., Shi, Y., Xiu, R., Wang, G., Liang, R., Jiao, Y., Shen, Z., Zhu, C., & Peng, G. (2021) · Journal of Virology · doi:10.1128/jvi.01955-21 · Cited by 7
mRNA vaccines and hybrid immunity use different B cell germlines to neutralize Omicron BA.4 and BA.5Preprint
Andreano, E., Paciello, I., Pierleoni, G., Maccari, G., Antonelli, G., Abbiento, V., Pileri, P., Benincasa, L., Giglioli, G., Piccini, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.04.502828 · Cited by 6
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spikePreprint
Tan, T. J. C., Mou, Z., Lei, R., Ouyang, W. O., Yuan, M., Song, G., Andrabi, R., Wilson, I. A., Kieffer, C., Dai, X., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.24.509341 · Cited by 6
Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines
Bangaru, S., Jackson, A. M., Copps, J., Fernández‐Quintero, M. L., Torres, J. L., Richey, S. T., Nogal, B., Sewall, L. M., de la Peña, A. T., Rehman, A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115986 · Cited by 6
Stepanenko, D., Wang, Y., & Simmerling, C. L. (2024) · Viruses · doi:10.3390/v16071066 · Cited by 5
Suryadevara, N., Kose, N., Bangaru, S., Binshtein, E., Munt, J. E., Martinez, D. R., Schäfer, A., Myers, L., Scobey, T., Carnahan, R. H., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178880 · Cited by 6
Virus–Receptor Interactions and Receptor-Mediated Virus Entry into Host Cells
Casasnovas, J. M. (2024) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-65187-8_15 · Cited by 5
Stuible, M., Schrag, J. D., Sheff, J. G., Zoubchenok, D., Lord‐Dufour, S., Cass, B., L’Abbé, D., Pelletier, A., Rossotti, M. A., Tanha, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-43661-2 · Cited by 6
Izadi, A., Godzwon, M., Söderlund‐Strand, A., Schmidt, T., Georén, S. K., Drosten, C., Ohlin, M., & Nordenfelt, P. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300675 · Cited by 5
Zhou, L., Wu, L., Peng, C., Yang, Y., Shi, Y., Gong, L., Xu, Z., & Zhu, W. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp05059a · Cited by 6
Garushyants, S., Rogozin, I. B., & Koonin, E. V. (2021) · Research Square · doi:10.21203/rs.3.rs-456574/v1 · Cited by 5
SARS-COV-2 δ variant drives the pandemic in India and Europe via two subvariantsPreprint
Yang, X. (2021) · medRxiv · doi:10.1101/2021.10.16.21265096 · Cited by 6
Mishra, T. K., Joshi, G., Kumar, A., Dalavi, R., Pandey, P., Shukla, S., Mishra, R. K., & Chande, A. G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.04.463028 · Cited by 5
Structural basis for antibody resistance to SARS-CoV-2 omicron variantPreprint
Cerutti, G., Guo, Y., Liu, L., Zhang, Z., Liu, L., Luo, Y., Huang, Y., Wang, H. H., Ho, D. D., Sheng, Z., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.21.473620 · Cited by 5
Self-citationA large-scale curated and filterable dataset for cryo-EM foundation model pre-training
Chen, Q., Xu, Z., Dai, H., Shen, Y., Zhang, J., Liu, Z., Pei, Y., & Jingyi Yu, A. (2025) · Scientific Data · doi:10.1038/s41597-025-05179-2 · Cited by 7
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections
Quirk, G., Schoenle, M. V., Peyton, K. L., Uhrlaub, J. L., Lau, B., Liang, C.-Y., Burgess, J. L., Ellingson, K., Beitel, S. C., Romine, J. K., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02162-2 · Cited by 5
Feng, H., Wang, Z., Li, L., Li, Y., Lu, M., Chen, X., Hu, L., Sun, Y., Du, R., Qin, R., et al. (2025) · Vaccines · doi:10.3390/vaccines13060592 · Cited by 4
Quaranta, M., Via, A., & Pascarella, S. (2025) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26855 · Cited by 4
Impact of Covishield Vaccination in Terms of SARS CoV-2 Neutralizing Antibody Expression
Thomas, R. E., Sukumaran, A., Arun Krishnan, R., Thomas, T., Edwin, B. T., Haritha, P. R., Varghese, B. M., Paul, J. K., S, S. K. C., & Vasudevan, D. M. (2022) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-022-01030-2 · Cited by 4
The Lambda Variant in Argentina: Analyzing the Evolution and Spread of SARS-CoV-2 Lineage C.37
Jodar, M. S. N., Torres, C., Mojsiejczuk, L. N., Acuña, D., Valinotto, L. E., Goya, S., Natale, M. I., Lusso, S. B., Alexay, S., Amadío, A., et al. (2023) · Viruses · doi:10.3390/v15061382 · Cited by 4
Zhang, T., Yang, D., Tang, L., & Hu, Y. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13272 · Cited by 5
Jhanwar, A., Sharma, D., & Das, U. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134850 · Cited by 4
Valgardsdottir, R., Cattaneo, I., Napolitano, G., Raglio, A., Spinelli, O., Salmoiraghi, S., Castilletti, C., Lapa, D., Capobianchi, M. R., Farina, C., et al. (2021) · Antibodies · doi:10.3390/antib10030026 · Cited by 4
Tuli, H. S., Sak, K., Aggarwal, P., Iqubal, A., Upadhaya, S. K., Kaur, J., Kaur, G., & Aggarwal, D. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.763687 · Cited by 4
Huhn, G. D., Poorbaugh, J., Zhang, L., Beasley, S., Nirula, A., Brothers, J., Welbel, S. F., Wilson, J., Gillani, S., Weber, K. M., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273323 · Cited by 4
Venkatakrishnan, A., Anand, P., Lenehan, P. J., Ghosh, P., Suratekar, R., Silvert, E., Pawlowski, C., Siroha, A., Chowdhury, D. R., O’Horo, J. C., et al. (2023) · Scientific Reports · doi:10.1038/s41598-022-26646-5 · Cited by 5
Cheung, K. S., Lam, L. K., Mao, X., Tan, J. T., Ooi, P. H., Zhang, R., Chan, K. H., Hung, I. F., Seto, W., & Yuen, M. (2023) · Vaccines · doi:10.3390/vaccines11030497 · Cited by 4
Li, K., Huntwork, R. H. C., Horn, G. Q., Abraha, M., Hastie, K. M., Li, H., Rayaprolu, V., Olmedillas, E., Feeney, E., Cronin, K. D., et al. (2023) · Journal of Virology · doi:10.1128/jvi.01070-23 · Cited by 4
Lerdsamran, H., Anusorntanawat, R., Sangsiriwut, K., Sawadpongpan, S., Prasertsopon, J., Thinpan, N., Intalapaporn, P., Techasuwanna, R., Okada, P. A., & Puthavathana, P. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298033 · Cited by 5
Allosteric modulation by the fatty acid site in the glycosylated SARS-CoV-2 spike
Oliveira, A. S. F., Kearns, F. L., Rosenfeld, M. A., Casalino, L., Tulli, L., Berger, I., Schaffitzel, C., Davidson, A. D., Amaro, R. E., & Mulholland, A. J. (2024) · eLife · doi:10.7554/elife.97313.3 · Cited by 7
A rational strategy for the maintenance of antiviral immunity to new SARS-CoV-2 strains
Baklaushev, V. P., Yusubalieva, G. M., Владимирович, Б. М., Yussubaliyeva, S. M., Анатольевич, К. В., & Troitskiy, A. V. (2022) · Journal of clinical practice · doi:10.17816/clinpract111120 · Cited by 4
Conformational dynamics and allosteric modulation of the SARS-CoV-2 spikePreprint
Díaz-Salinas, M. A., Li, Q., Ejemel, M., Yurkovetskiy, L., Luban, J., Shen, K., Wang, Y., & Munro, J. B. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.29.466470 · Cited by 4
Structural dynamics in the evolution of SARS-CoV-2 spike glycoproteinPreprint
Calvaresi, V., Wrobel, A. G., Toporowska, J., Hammerschmid, D., Doores, K. J., Bradshaw, R. T., Parsons, R. B., Benton, D. J., Roustan, C., Reading, E., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2049401/v1 · Cited by 4
Identification and Ranking of Binding Sites from Structural Ensembles: Application to SARS-CoV-2
Lazou, M., Bekar-Cesaretli, A. A., Vajda, S., & Joseph‐McCarthy, D. (2024) · Viruses · doi:10.3390/v16111647 · Cited by 3
Optimizing the breadth of SARS-CoV-2-neutralizing antibodies in vivo and in silico
Kuroda, D., Moriyama, S., Sasaki, H., & Takahashi, Y. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2526873 · Cited by 3
Wang, S., Sun, H., Wang, Y., Wang, Z., Yuan, L., Guo, H., Gao, J., Lan, M., Wu, Y., Shang, H., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2503254122 · Cited by 4
Ert, H. A. V., Bohan, D., Rogers, K. J., Fili, M., Chávez, R. A. R., Qing, E., Han, C., Dempewolf, S., Hu, G., Schwery, N., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02676-21 · Cited by 3
Site-directed neutralizing antibodies targeting structural sites on SARS-CoV-2 spike protein
Li, X., Kulakova, L., Jones, K. S., Toth, E. A., Kirkland, M. E., Mendez, Q. M., Weiner, M. P., & Fuerst, T. R. (2023) · New Biotechnology · doi:10.1016/j.nbt.2023.12.004 · Cited by 3
Dynamic expedition of leading mutations in SARS-CoV-2 spike glycoproteins
Hasan, M., He, Z., Jia, M., Leung, A. C. F., Natarajan, K., Xu, W., Yap, S., Zhou, F., Chen, S., Su, H., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.05.037 · Cited by 3
Grassmann, G., Miotto, M., Alessandrini, F., Bo’, L., Ruocco, G., Milanetti, E., & Giansanti, A. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.10.033 · Cited by 3
Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum
Zhu, Y., Yang, X., Xun, J., Liu, J., Wen, Q., Lin, Y., Shen, X., Chen, J., Yuan, S., Zhao, X., et al. (2022) · Virologica Sinica · doi:10.1016/j.virs.2022.10.006 · Cited by 3
Self-citation
Metadata
- Authors
- Cerutti, G., Guo, Y., Zhou, T., Gorman, J., Lee, M., Rapp, M., Reddem, E. R., Yu, J., Bahna, F., Bimela, J., Huang, Y., Katsamba, P. S., Liu, L., Nair, M. S., Rawi, R., Olia, A. S., Wang, P., Zhang, B., Chuang, G.-Y., Ho, D. D., Sheng, Z., Kwong, P. D., & Shapiro, L.
- Affiliations
- Mortimer B. Zuckerman Mind Brain Behavior Institute (US)
- National Institutes of Health (US)
- Aaron Diamond AIDS Research Center (US)
- Corresponding author
- Kwong, Peter D.
- Shapiro, Lawrence
- ORCID
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 29
- Issue
- 5
- Pages
- 819-833.e7
- ISSN
- 1931-3128 (ISSN-L)
- PMC
- PMC7953435
- OpenAlex
- W3136437538
- Cited by
- 519
- References
- 89
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 67 · 2023: 93 · 2022: 141 · 2021: 151
- FWCI
- 35.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Host & Microbe (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Simons Foundation (SF349247)
- National Institute of General Medical Sciences (GM103310, GM129539)
- National Institutes of Health (P41 GM103403, P30 GM124165)
- Vaccine Research Center
- Office of Science (W-31-109-Eng-38)
- Empire State Development's Division of Science, Technology and Innovation
- Basic Energy Sciences
- U.S. Department of Energy
- National Institute of Allergy and Infectious Diseases
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- SARS-CoV-2, neutralizing antibodies, antibody-antigen complex structure, cryo-EM structure, crystal structure, glycans, beta-hairpin, epitope mapping, convalescent donors, receptor binding domain
- MeSH terms
- Protein Domains, SARS-CoV-2, Antibodies, Viral, Humans, Mutation, Protein Conformation, Antibodies, Neutralizing, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
